news

UCalgary study finds certain medications decrease diversity and beneficial microorganisms found in the gut, which may affect overall health Our intestines house trillions of microorganisms known as the gut microbiota. These microorganisms are important players in both drug metabolism and certain conditions like high blood pressure, coronary artery disease and diabetes.

Waterloo Pharmacy researchers collaborate with QRxDigital to make prescriptions easier to understand Being able to understand the medications you take should be a given. However, many people struggle to understand what to expect from the medications they're taking and how to take them effectively. Waterloo's clinical associate professor, Dr. Tejal Patel, has teamed up with QRxDigital to include QR codes on medication bottles that link to an instructional video that patients can view at home.

Patented bandage contact lens material could release drugs as needed to help eye abrasions heal faster A cross-disciplinary University of Waterloo team has developed a new contact lens material that could act as a bandage for corneal wounds while releasing drugs in a controlled manner to help the eye heal faster.

UCalgary researchers investigate the science of psilocybin-assisted treatment for alcohol use disorder Clinical trial to explore potential of psychedelics combined with therapy to help someone reduce or stop drinking University of Calgary researchers are about to conduct the largest single-site clinical trial of its kind in Canada to find out whether combining a known therapy with psychedelics could be a viable treatment for alcohol use disorder (AUD).

A new study suggests that a combined vaccine approach could be an effective avenue for preventing severe SARS-CoV-2 infections and reducing transmission of COVID-19. A study led by Dr. Hélène Decaluwe , professor in the Department of Pediatrics at the Université de Montréal and researcher at CHU Sainte-Justine, suggests that a combined approach of intramuscular and mucosal vaccines could be an effective avenue for preventing severe SARS-CoV-2 infections and reducing transmission of COVID-19.

Stéphanie Forté and co-researchers in Canada and Brazil have shown how people with sickle cell disease or sickle cell trait have a higher chance of dying from COVID-19 than the general population. Patients with sickle cell disease and carriers of the sickle cell trait, often considered benign, face higher rates of death and hospitalization if they contract COVID-19, a new Canada-Brazil study suggests.

Researchers at UBC's faculty of medicine are launching a first-of-its-kind clinical trial investigating the potential of cannabidiol (CBD) as a treatment for bipolar depression. Bipolar disorder is a chronic mental health condition characterized by extreme changes in mood that cycle through periods of intense highs (mania) and lows (depression).

Team led by researchers from Western, St. Michael's Hospital and U of T finds deficient vessel repair a major factor A new study involving researchers at Western University, St. Michael's Hospital and University of Toronto has found that South Asians with either heart disease or diabetes had fewer vascular regenerative and reparative cells compared to white European patients.

Researchers design gel from wood pulp to heal damaged heart tissue and improve cancer treatments You can mend a broken heart this Valentine's Day now that researchers invented a new hydrogel that can be used to heal damaged heart tissue and improve cancer treatments. University of Waterloo chemical engineering researcher Dr. Elisabeth Prince teamed up with researchers from the University of Toronto and Duke University to design the synthetic material made using cellulose nanocrystals, which are derived from wood pulp.

Scientists have developed an experimental medication called UBX1325, or foselutoclax, that shows promise in treating macular edema. Diabetes can lead to eye problems, and a common one is diabetic macular edema (DME), causing vision loss. Now a study published in Nature Medicine suggest a new experimental drug could someday help make treatment of DME more successful and longer-lasting.

The 3,000-km artery contains a large quantity and variety of pharmaceutical compounds, some of which could be harmful to ecosystems and human health. A new study shows troubling levels of pharmaceutical pollution in the St. Lawrence River and its largest tributaries, especially near and downstream of urban areas.

Following a program of physical exercise combined with cognitive training can greatly help older people with mild cognitive impairment, a national study finds. Symptoms of mild cognitive impairment in the elderly can be slowed or even reversed if they follow a combined program of physical exercise and cognitive training, according to the results of a clinical study of 175 seniors diagnosed with the disorder.

Major work led by Dr. André Veillette's team in collaboration with a group of researchers managed to identify a previously unknown way which prevents phagocytosis. Major work led by Dr. André Veillette's team at the Institut de recherches cliniques de Montréal (IRCM), in collaboration with a group of researchers, and just published in Nature Immunology , managed to identify a previously unknown way which prevents phagocytosis, which is a process that promotes the immune system's response to cancer.

Science, Health & Technology Erik Rolfsen Researchers from the University of B.C. and the BC Provincial Toxicology Centre (BCPTC) have developed a more efficient way to find out which new 'designer drugs' are circulating in the community. In a study published today in Analytical Chemistry , they showed how high-resolution mass spectrometry can be used to analyze urine samples at scale and uncover molecules from emerging designer drugs that have been missed by conventional testing.

Science, Health & Technology Brett Goldhawk A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient outcomes, according to new research from the University of British Columbia.

A research team from Université Laval demonstrates how this drug acts on adipose tissue The ways of science are sometimes impenetrable, they say. Bimatoprost, a drug used to relieve ocular hypertension and give fuller eyelashes, is now helping to open up new horizons in the understanding and treatment of obesity.

A study at the UdeM-affiliated Montreal Clinical Research Insitute paves the way for more early diagnostic and therapeutic options to detect and treat these two major metabolic diseases. Canadian scientists have found a new link between two major metabolic diseases: diabetes and steatotic liver disease, commonly known as fatty liver disease.

Researchers combining bioprinting with synthetic chips to understand tumours in 3D An international team of interdisciplinary researchers has successfully created a method for better 3D modelling of complex cancers. The University of Waterloo-based team combined cutting-edge bioprinting techniques with synthetic structures or microfluidic chips.

Atrial fibrillation detected after stroke seems more benign than pre-stroke irregular heartbeats, finds Western study Worldwide, millions of stroke survivors undergo prolonged cardiac monitoring, leading to the discovery of atrial fibrillation, or irregular heartbeats, in up to 1.5 million of these patients each year.

Waterloo Pharmacy researchers find an opportunity to improve vaccination uptake HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.